Skip to main content
Top

Risk Stratification Strategies and Implementation of Exercise Training in Patients with Multiple Myeloma

Abstract

Purpose of Review

This review aims to explore key clinical considerations for prescribing exercise in individuals with multiple myeloma (MM) and to evaluate current evidence to develop exercise regimens that prioritize both safety and efficacy.

Recent Findings

MM is a hematological cancer characterized by complex complications, including unstable bone lesions, cardiac amyloidosis, peripheral neuropathy, and cytopenia, which collectively impair patients' health and quality of life. Exercise training has emerged as a critical component of supportive care in MM; however, the complexity of the disease and its associated comorbidities pose challenges to designing safe and effective interventions. Recent evidence underscores the potential benefits of aerobic and resistance training, yet there is no consensus on optimal exercise protocols. Tools such as cardiopulmonary exercise testing, fracture risk assessment, and blood biomarker monitoring have shown promise in personalizing exercise prescriptions.

Summary

Although the feasibility and short-term benefits of exercise interventions for MM are well-established, significant gaps in knowledge persist regarding their long-term effects on disease progression, survival, and quality of life. Future research is needed to address these gaps and refine evidence-based exercise guidelines for this unique patient population.

Graphical Abstract

Title
Risk Stratification Strategies and Implementation of Exercise Training in Patients with Multiple Myeloma
Authors
Sung-Soo Park
Eui-Soon Kim
Jong-Chan Youn
Mi-Hyang Jung
Jihye Park
Kyung Eun Nam
Chang-Ki Min
Saro H. Armenian
Kyuwan Lee
Publication date
03-11-2025
Publisher
Springer US
Published in
Current Oncology Reports
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-025-01719-6
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Prof. Harpreet Wasan
Join the webinar
Webinar
SPONSORED

Masterclass webinar: Expert review of CAR T-cell therapy patient cases in R/R DLBCL or R/R FL

Join Professor Joy Ho as she leads a panel of Asia-Pacific-based experts, discussing real-life patient cases and their experiences with CAR T-cell therapy for the treatment of R/R DLBCL or R/R FL. Learn about how to identify appropriate patients for CAR T-cell therapy and how to optimize outcomes with this treatment modality. Gain insights into essential aspects of pre- and post-infusion management, as well as important considerations for treatment sequencing.

This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.

Sponsored by:
  • Novartis Pharma AG
Prof. Joy Ho
Prof. William Hwang
Dr. Kentaro Fukushima
Prof. Dok Hyun Yoon
Prof. Miki Ando
Developed by: Springer Health+
Learn more
Video
Image Credits
Senior man using a resistance band in an exercise class/© Drazen Zigic / Getty Images (symbolic image with models), Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, CAR T-cell attacking cancer cells/© LoveLive/stock.adobe.com